相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Effects of adalimumab therapy on disease activity and interferon-γ-mediated biochemical pathways in patients with rheumatoid arthritis
Katharina Kurz et al.
AUTOIMMUNITY (2011)
Marginal zone macrophages suppress innate and adaptive immunity to apoptotic cells in the spleen
Tracy L. McGaha et al.
BLOOD (2011)
Multiple sclerosis, seizures, and antiepileptics: role of IL-18, IDO, and melatonin
G. Anderson et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
CD169-Positive Macrophages Dominate Antitumor Immunity by Crosspresenting Dead Cell-Associated Antigens
Kenichi Asano et al.
IMMUNITY (2011)
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells
Maria T. Pallotta et al.
NATURE IMMUNOLOGY (2011)
TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus
Cristiana Guiducci et al.
NATURE (2010)
Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes
Madhav D. Sharma et al.
BLOOD (2009)
Apoptotic Cells Promote Their Own Clearance and Immune Tolerance through Activation of the Nuclear Receptor LXR
Noelia A-Gonzalez et al.
IMMUNITY (2009)
A Defect in Marco Expression Contributes to Systemic Lupus Erythematosus Development via Failure to Clear Apoptotic Cells
Nicola Jane Rogers et al.
JOURNAL OF IMMUNOLOGY (2009)
Deficiency of Type I IFN Receptor in Lupus-Prone New Zealand Mixed 2328 Mice Decreases Dendritic Cell Numbers and Activation and Protects from Disease
Hemant Agrawal et al.
JOURNAL OF IMMUNOLOGY (2009)
IDO Activates Regulatory T Cells and Blocks Their Conversion into Th17-Like T Cells
Babak Baban et al.
JOURNAL OF IMMUNOLOGY (2009)
ATF4-dependent transcription mediates signaling of amino acid limitation
Michael S. Kilberg et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2009)
Indoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethality
Lisa K. Jasperson et al.
BLOOD (2008)
Apoptotic cells induce dendritic cell-mediated suppression via interferon-γ-induced IDO
Charlotte A. Williams et al.
IMMUNOLOGY (2008)
Cutting edge:: Autocrine TGF-β sustains default tolerogenesis by IDO-competent dendritic cells
Maria L. Belladonna et al.
JOURNAL OF IMMUNOLOGY (2008)
Class A scavenger receptors regulate tolerance against apoptotic cells, and autoantibodies against these receptors are predictive of systemic lupus
Fredrik Wermeling et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase
Madhav D. Sharma et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Critical role of macrophages in the marginal zone in the suppression of immune responses to apoptotic cell-associated antigens
Yasunobu Miyake et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan
Richard Metz et al.
CANCER RESEARCH (2007)
Cutting edge:: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN type 1 signaling
AL Mellor et al.
JOURNAL OF IMMUNOLOGY (2005)
A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type IIFN signaling following B7 ligation
B Baban et al.
INTERNATIONAL IMMUNOLOGY (2005)
Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation
E Kwidzinski et al.
FASEB JOURNAL (2005)
Restoration of tolerance in lupus by targeted inhibitory receptor expression
TL McGaha et al.
SCIENCE (2005)
Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific
B Baban et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2004)
Accelerated autoimmune disease in MRL/MpJ-Faslpr but not in MRL/MpJ following immunization with high load of syngeneic late apoptotic cells
Y Shoshan et al.
AUTOIMMUNITY (2004)
Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice
ML Santiago-Raber et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta 1 secretion and the resolution of inflammation
MLN Huynh et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)